Sophia Primary Analysis: A Phase 3 (P3) Study Of Margetuximab (M) Plus Chemotherapy (C) Versus Trastuzumab (T) Plus C In Patients (Pts) With Her2+Metastatic (Met) Breast Cancer (Mbc) After Prior Anti-Her2 Therapies (Tx).

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 99|浏览48
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要